Are endoscopic antireflux therapies cost-effective compared with laparoscopic fundoplication?

Endoscopy

Volumn 37, Issue 3, 2005, Pages 217-222

  Schiefke, I ^a   Rogalski, C ^a   Zabel Langhennig, A ^a   Witzigmann, H ^a   Mossner J ^a   Hasenclever, D ^a   Caca, K ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC THERAPY; GASTROESOPHAGEAL REFLUX; GERMANY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; PRIORITY JOURNAL; PUBLICATION; RADIOFREQUENCY; STOMACH FUNDOPLICATION; SURGICAL INSTRUMENT; SUTURING METHOD; TREATMENT FAILURE; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DECISION MAKING; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; GERMANY; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LAPAROSCOPY; MODELS, ECONOMIC;

EID: 14944364792     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-860996     Document Type: Article

References (44)

1. Dimenas E, Glise H, Hallerback B et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-687
2. Locke GR, 3rd, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456
3. Revicki DA, Sorensen S, Maton PN, Orlando RC. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998; 16: 284-291
4. el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327-333
5. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589-1594
6. Voutilainen M, Sipponen P, Mecklin JP et al. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13
7. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
8. Klinkenberg-Knol EC, Festen HP, Jansen JB et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994; 121: 161-167
9. Vigneri S, Termini R, Leandro G et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995; 333: 1106-1110
10. Spechler SJ, Lee E, Ahnen D et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001; 285: 2331-2338
11. Lundell L. Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist. Gut 2002; 51: 468-471
12. Hetzel DJ, Dent J, Reed WD et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903-912
13. McDougall NI, Johnston BT, Kee F et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-486
14. Donahue PE, Samelson S, Nyhus LM, Bombeck CT. The floppy Nissen fundoplication. Effective long-term control of pathologic reflux. Arch Surg 1985; 120: 663-668
15. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg 1986; 204: 9-20
16. Thor KB, Silander T. A long-term randomized prospective trial of the Nissen procedure versus a modified Toupet technique. Ann Surg 1989; 210: 719-724
17. Dallemagne B, Weerts JM, Jehaes C et al. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc 1991; 1: 138-143
18. Fuchs KH, Feussner H, Bonavina L et al. Current status and trends in laparoscopic antireflux surgery: results of a consensus meeting. The European Study Group for Antireflux Surgery (ESGARS). Endoscopy 1997; 29: 298-308
19. Lafullarde T, Watson DI, Jamieson GG et al. Laparoscopic Nissen fundoplication: five-year results and beyond. Arch Surg 2001; 136: 180-184
20. Pelissier EP, Ottignon Y, Deschamps JP, Carayon P. Fundoplication avoiding complications of the Nissen procedure: prospective evaluation. World J Surg 1997; 21: 611-616; discussion 616-617
21. Wetscher GJ, Glaser K, Wieschemeyer T et al. Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia. World J Surg 1997; 21: 605-610
22. Bais JE, Bartelsman JF, Bonjer HJ et al. Laparoscopic or conventional Nissen fundoplication for gastro- oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000; 355: 70-174
23. Pessaux P, Arnaud JP, Ghavami B et al. Morbidity of laparoscopic fundoplication for gastroesophageal reflux: a retrospective study about 1470 patients. Hepatogastroenterology 2002; 49: 447-450
24. Van Den Boom G, Go PM, Hameeteman W et al. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996; 31: 1-9
25. Swain CP, Brown GJ, Gong F, Mills TN. An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract. Gastrointest Endosc 1994; 40: 730-734
26. Filipi CJ, Lehman GA, Rothstein RI et al. Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial. Gastrointest Endosc 2001; 53: 416-422
27. Mahmood Z, McMahon BP, Arfin Q et al. Endocinch therapy for gastrooesophageal reflux disease: a one year prospective follow up. Gut 2003; 52: 34-39
28. Tam WC, Holloway RH, Dent J et al. Impact of endoscopic suturing of the gastroesophageal junction on lower esophageal sphincter function and gastroesophageal reflux in patients with reflux disease. Am J Gastroenterol 2004; 99: 195-202
29. Ponchon T, Boyer J, Grimaud JC et al. A prospective multicenter phase II study to evaluate endocinch suturing system for the treatment of GERD. Gastrointest Endosc 2004; 60: AB15
30. Triadafilopoulos G, Dibaise JK, Nostrant TT et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc 2001; 53: 407-415
31. Triadafilopoulos G, DiBaise JK, Nostrant TT et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002; 55: 149-156
32. Corley DA, Katz P, Wo JM et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003; 125: 668-676
33. Tam WC, Schoeman MN, Zhang Q et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 2003; 52: 479-485
34. Mason RJ, Hughes M, Lehman GA et al. Endoscopic augmentation of the cardia with a biocompatible injectable polymer (Enteryx) in a porcine model. Surg Endosc 2002; 16: 386-391
35. Deviere J, Pastorelli A, Louis H et al. Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study. Gastrointest Endosc 2002; 55: 335-341
36. Johnson DA, Ganz R, Aisenberg J et al. Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am J Gastroenterol 2003; 98: 250-258
37. Johnson DA, Ganz R, Aisenberg J et al. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multi-center trial. Am J Gastroenterol 2003; 98: 1921-1930
38. Johansson J, Johnsson F, Joelsson B et al. Outcome 5 years after 360 degree fundoplication for gastro-oesophageal reflux disease. Br J Surg 1993; 80: 46-49
39. Carlson MA, Frantzides CT. Complications and results of primary minimally invasive antireflux procedures: a review of 10,735 reported cases. J Am Coll Surg 2001; 193: 428-439
40. Flum DR, Koepsell T, Heagerty P, Pellegrini CA. The nationwide frequency of major adverse outcomes in antireflux surgery and the role of surgeon experience, 1992-1997. J Am Coll Surg 2002; 195: 611-618
41. Velanovich V, Ben Menachem T. Laparoscopic Nissen fundoplication afte0r failed endoscopic gastroplication. J Laparoendosc Adv Surg Tech A 2002; 12: 305-308
42. El Nakadi I, Closset J, De Moor V et al. Laparoscopic Nissen fundoplication after failure of Enteryx injection into the lower esophageal sphincter. Surg Endosc 2004; 18: 818-820
43. Mahmood Z, McMahon B, O'Morain C, Weir DG. Innovations in gastro-intestinal endoscopy: endoscopic antireflux therapies for gastro-oesophageal reflux disease. Dig Dis 2002; 20: 182-190
44. Harewood GC, Gostout CJ. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Gastrointest Endosc 2003; 58: 493-499